Pangea Wellness Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	0.01	0.01	0.29	0.58	0.12
Revenue Growth (YoY)	-49.04%	-95.73%	-50.84%	394.79%	-
Cost of Revenue	0	0.07	0.32	0.54	0.13
Gross Profit	0	-0.06	-0.03	0.04	-0.01
Selling, General & Admin	1.5	0.79	1.23	0.82	0.28
Research & Development	0.03	0.03	-	-	-
Operating Expenses	1.6	0.96	1.61	0.94	0.28
Operating Income	-1.6	-1.02	-1.64	-0.9	-0.3
Currency Exchange Gain (Loss)	-0.05	0	-0.01	-0.01	-0
Other Non Operating Income (Expenses)	0	-	-	-0.19	-
EBT Excluding Unusual Items	-1.65	-1.02	-1.65	-1.09	-0.3
Asset Writedown	-0.01	-0.01	-0.01	-0.04	-
Pretax Income	-1.66	-1.03	-1.66	-1.13	-0.3
Net Income	-1.66	-1.03	-1.66	-1.13	-0.3
Net Income to Common	-1.66	-1.03	-1.66	-1.13	-0.3
Shares Outstanding (Basic)	15	7	6	5	1
Shares Outstanding (Diluted)	15	7	6	5	1
Shares Change (YoY)	140.44%	17.56%	24.54%	589.41%	-
EPS (Basic)	-0.11	-0.15	-0.29	-0.25	-0.45
EPS (Diluted)	-0.11	-0.15	-0.29	-0.25	-0.45
Free Cash Flow	-0.42	-0.44	-0.98	-0.72	-0.95
Free Cash Flow Per Share	-0.03	-0.07	-0.17	-0.16	-1.43
Gross Margin	50.40%	-	-11.48%	7.04%	-10.69%
Operating Margin	-22860.38%	-8354.01%	-575.40%	-154.78%	-252.00%
Profit Margin	-23694.22%	-8450.19%	-581.35%	-194.13%	-252.86%
Free Cash Flow Margin	-6006.57%	-3601.16%	-343.39%	-123.69%	-808.45%
EBITDA	-1.55	-1.02	-1.64	-0.9	-0.29
EBITDA Margin	-	-	-	-154.64%	-250.67%
D&A For EBITDA	0.05	0	0	0	0
EBIT	-1.6	-1.02	-1.64	-0.9	-0.3
EBIT Margin	-	-	-	-154.78%	-252.00%
Advertising Expenses	-	0.04	0.38	0.27	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.